Effect of metronidazole and modulation of cytokine production on human periodontal ligament cells

International Immunopharmacology

Volumn 10, Issue 7, 2010, Pages 744-750

  Rizzo, Antonietta ^a   Paolillo, Rossella ^a   Guida, Luigi ^b   Annunziata, Marco ^b   Bevilacqua, Nazario ^c   Tufano, Maria Antonietta ^a  

^a Faculty of Medicine and Surgery   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c CARDARELLI HOSPITAL   (Italy)

Author keywords

Cytokines; Human periodontal ligament cells; Metronidazole

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE; MESSENGER RNA; METRONIDAZOLE; METRONIDAZOLO; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY TEST; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; PERIODONTAL LIGAMENT; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL;

ADULT; ANTI-INFECTIVE AGENTS; BACTEROIDACEAE INFECTIONS; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; FEMALE; HUMANS; INFLAMMATION MEDIATORS; MALE; METRONIDAZOLE; PERIODONTAL LIGAMENT; PERIODONTITIS; PORPHYROMONAS GINGIVALIS;

EID: 77953026742     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.04.004     Document Type: Article

References (47)

1. Offenbacher S. Periodontal diseases: pathogenesis. Ann Periodontol 1 (1996) 821-878
2. Zambon J.J. Periodontal diseases: microbial factors. Ann Periodontol 1 (1996) 879-925
3. Cazalis J., Tanabe S., Gagnon G., Sorsa T., and Grenier D. Tetracyclines and chemically modified tetracycline-3 (CMT-3) modulate cytokine secretion by lipopolysaccharide-stimulated whole blood. Inflammation 32 (2009) 130-137
4. Kornman K.S., Page R.C., and Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology 2000 14 (1997) 33-53
5. Ebersole J.L., and Taubman M.A. The protective nature of host responses in periodontal diseases. Periodontology 2000 5 (1994) 112-141
6. Okada H., and Murakami S. Cytokine expression in periodontal health and disease. Crit Rev Oral Biol Med 9 (1998) 248-266
7. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction periodontal. J Periodontal Res 28 (1993) 500-510
8. Wilson Jr. T.G. Supportive periodontal treatment introduction-definition, extent of need, therapeutic objectives, frequency and efficacy. Periodontology 2000 12 (1996) 11-15
9. Douglass C.W. Risk assessment and management of periodontal disease. J Am Dent Assoc 137 (2006) 27S-32S Review. Erratum in: J Am Dent Assoc 2008; 139: 252.
10. Haffajee A.D., Socransky S.S., and Gunsolley J.C. Systemic anti-infective periodontal therapy. A systematic review. Ann Periodontol 8 (2003) 115-181
11. Salvi G.E., Mombelli A., Mayfield L., Rutar A., Suvan J., Garrett S., et al. Local antimicrobial therapy after initial periodontal treatment. J Clin Periodontol 29 (2002) 540-550
12. Hanes P.J., and Purvis J.P. Local anti-infective therapy: pharmacological agents. A systematic review. Ann Periodontol 8 (2003) 79-98
13. Bonito A.J., Lux L., and Lohr K.N. Impact of local adjuncts to scaling and root planing in periodontal disease therapy: a systematic review. J Periodontol 76 (2005) 1227-1236
14. Frey H.H., and Löscher W. Lehrbuch der pharmakologie und toxicology für die veterinary-medizin (1996), Enke, Stuttgart 502-503
15. Edwards D.I. Nitroimidazole drugs-action and resistance mechanisms. I. Mechanisms of action. J Antimicrob Chemother 31 (1993) 9-20
16. Freeman C.D., Klutman N.E., and Lamp K.C. Metronidazole. A therapeutic review and update. Drugs 54 (1997) 679-708
17. Lamp K.C., Freeman C.D., Klutman N.E., and Lacy M.K. Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials. Clin Pharmacokinet 36 (1999) 353-373
18. Roe F.J. Toxicologic evaluation of metronidazole with particular reference to carcinogenic, mutagenic, and teratogenic potential. Surgery 93 (1983) 158-164
19. Noyan U., Yilmaz S., Kuru B., Kadir T., Acar O., and Büget E. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients. J Clin Periodontol 24 (1997) 158-165
20. Van Oosten M.A., Notten F.J., and Mikx F.H. Metronidazole concentrations in human plasma, saliva, and gingival crevice fluid after a single dose. J Dent Res 65 (1986) 1420-1423
21. Eng R.H., Smith S.M., Fan-Havard P., and Ogbara T. The effect of antibiotics on endotoxin release from gram-negative bacteria. Diagn Microbiol Infect Dis 16 (1993) 185-189
22. Stevens D.L., Byrant A.E., and Hackett S.P. Antibiotic effects on bacterial viability, toxin production and host responses. Clin Infect Dis 20 Suppl 2 (1995) 154-157
23. Mock C.N., Jurovich G.J., Dries D.J., and Maier R.V. Clinical significance of antibiotic endotoxin-releasing properties in trauma patients. Arch Surg 13 (1995) 1234-1239
24. Dongari-Bagtzoglou A., and Emersole J.L. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 31 (1996) 90-98
25. Darveau R.P., and Hancock R.E. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J Bacteriol 155 (1983) 831-838
26. Hirono S., Dibrov E., Hurtado C., Kostenuk A., Ducas R., and Pierce G.N. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous Heat Shock Protein 60. Circ Res 93 (2003) 710-716
27. Hongo T., Fujii Y., and Igarashi Y. An in vitro chemosensitivity test for the screening of anti-cancer drugs in childhood leukemia. Cancer 65 (1990) 1263-1271
28. Durkin W.J., Ghanta V.K., and Hiramoto R.N. Results obtained using a vital dye exclusion assay and clinical correlations. In: Dendy P.P., and Hill B.T. (Eds). Human tumor drug sensitività testing in vitro (1983), Academic Press, London 259-268
29. Green L.M., Reade J.L., and Ware C.F. Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines. J Immunol Methods 70 (1984) 257-268
30. Kornblith P.L., and Szypko P.E. Variations in response of human brain tumors to BCNU in vitro. J Neurosurg 8 (1978) 580-586
31. Cornelsen Gencay M.M., Tamm M., Glanville A., Perruchoud A.P., and Roth M. Chlamydia pneumoniae activates epithelial cell proliferation via NF-κB and the glucocorticoid receptor. Infect Immun 71 (2003) 5814-5822
32. Dolfini E., Elli L., Roncoroni L., Costa B., Colleoni M.P., Lorusso V., et al. Damaging effects of gliadin on three-dimensional cell culture model. World J Gastroenterol 11 (2005) 5973-5977
33. Listgarten M.A. Pathogenesis of periodontitis. J Clin Periodontol 13 (1986) 418-430
34. Krehmeier U., Bardenheuer M., Voggenreiter G., Obertacke U., Schade F.U., and Majetschak M. Effects of antimicrobial agents on spontaneous and endotoxin-induced cytokine release of human peripheral blood mononuclear cells. J Infect Chemother 8 (2002) 194-197
35. Buchner Y., and Edwards D.I. The effect of metronidazole and nitrofurans on the morphology of Trichomonas vaginalis. J Antimicrob Chemother 1 (1975) 229-234
36. Carosi G., Filice G., Suter F., and Dei Cas A. Trichomonas vaginalis: effect of tinidazole on ultrastructure in vitro. Exp Parasitol 43 (1977) 315-325
37. Almasri A., Wisithphrom K., Windsor L.J., and Olson B. Nicotine and lipopolysaccharide affect cytokine expression from gingival fibroblasts. J Periodontol 78 (2007) 533-541
38. Chiang C.Y., Kyritsis G., Graves D.T., and Amar S. Interleukin-1 and tumor necrosis factor activities partially account for calvarial bone resorption induced by local injection of lipopolysaccharide. Infect Immun 67 (1999) 4231-4236
39. Gemmell E., Marshall R.I., and Seymour G.J. Cytokines and prostaglandins in immune homeostasis and tissue destruction in periodontal disease. Periodontology 2000 14 (1997) 112-143
40. Gamonal J., Acevedo A., Bascones A., Jorge O., and Silva A. Levels of interleukin-1 beta, -8, and -10 and RANTES in gingival crevicular fluid and cell populations in adult periodontitis patients and the effect of periodontal treatment. J Periodontol 71 (2000) 1535-1545
41. Roberts F.A., Hockett Jr. R.D., Bucy R.P., and Michalek S.M. Quantitative assessment of inflammatory cytokine gene expression in chronic adult periodontitis. Oral Microbiol Immunol 12 (1997) 336-344
42. Assuma R., Oates T., Cochran D., Amar S., and Graves D.T. IL-1 and TNF antagonists inhibit the inflammatory response and bone loss in experimental periodontitis. J Immunol 1 160 (1998) 403-409
43. Takahashi K., Takashiba S., Nagai A., Takigawa M., Myoukai F., Kurihara H., et al. Assessment of interleukin-6 in the pathogenesis of periodontal disease. J Periodontol 65 (1994) 147-153
44. Löwik C.W., van der Pluijm G., Bloys H., Hoekman K., Bijvoet O.L.M., Aarden L.A., et al. Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: a possible role of interleukin-6 in osteoclastogenesis. Biochem Biophys Res Commun 162 (1989) 1546-1552
45. Gamonal J., Acevedo A., Bascones A., Jorge O., and Silva A. Characterization of cellular infiltrate, detection of chemokine receptor CCR5 and interleukin-8 and RANTES chemokines in adult periodontitis. J Periodontal Res 36 (2001) 194-203
46. Horwood N.J., Elliott J., Martin T.J., and Gillespie M.T. IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166 (2001) 4915-4921
47. Yamada N., Niwa S., Tsujimura T., Iwasaki T., Sugihara A., Futani H., et al. Interleukin-18 and interleukin-12 synergistically inhibit osteoclastic bone-resorbing activity. Bone 30 (2002) 901-908